FDA Medical devices recall ·

Dexcom G6, Continuous Glucose Monitoring System recall

Recall number
Z-1204-2025
Date
(initiated January 27, 2025)
Company / brand
Dexcom, Inc.
6340 Sequence Dr, San Diego, CA, United States
Category
Medical devices › Class II
Classification
Class II
Status
Ongoing
Units affected
N/A
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Dexcom G6, Continuous Glucose Monitoring System, REF: STK-OE-001

Why was it recalled?

Under very rare situations, the Dexcom G6 touchscreen receiver may not provide high or low glucose alarms/alerts as designed, which can result in two different conditions. First, if a receiver operating system .net error occurs when an alarm/alert should be triggered, the initial alarm/alert will not be delivered until a subsequent alarm/alert is triggered. At that time, the initial alarm/alert is delivered, but not the second one. Alarm/alerts will continue to be delayed and be one alarm/alert behind, causing delayed alarm/alerts until the receiver is reset. This condition could result in the missed detection of a hyperglycemic or hypoglycemic event. Second, a single EGV reading may be delayed for 5 minutes after the initial .net operating system error. If the user receives a single EGV reading delayed by 5 minutes, the delay is not expected to cause user harm.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

All Serial Numbers/UDI: 00386270001900

Distribution

Worldwide - US Nationwide distribution in the states of OH, TX, PA, MN, SC, NH, FL, CA, NJ, PR, GA and the countries of Austria, Belgium, Canada, Switzerland, Germany, Spain, France, Ireland, Japan, Netherlands, Slovenia, United Kingdom, Australia, Czech Republic, Denmark, Finland, France, Hong Kong, Israel, Italy, Korea, Kuwait, New Zealand, Norway, Oman, Poland, Qatar, Saudi Arabia, Singapore, Slovakia, South Africa, Sweden, Turkey, United Arab Emirates.

States: California Florida Georgia Minnesota New Hampshire New Jersey Ohio Pennsylvania Puerto Rico South Carolina Texas

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (medical devices), recall Z-1204-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.